Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

DM-199 increases C-peptide levels in animal model

Dec. 9, 2011

Novel GPR119 receptor agonists disclosed by Boehringer Ingelheim

Dec. 9, 2011

U.S. university extracts novel agents with antidiabetic potential from African shrub

Dec. 9, 2011

New diacylglycerol O-acyltransferase 1 inhibitors show potential to treat obesity and/or diabetes

Dec. 9, 2011

Sanofi reports data from GetGoal Duo 1 study

Dec. 9, 2011

Phase I trial of Antisense Therapeutics product meets endpoint

Dec. 9, 2011

New 11-beta-HSD1 inhibitors patented in Korea

Dec. 7, 2011

Novel GPR119 receptor agonists disclosed by Bristol-Myers Squibb

Dec. 7, 2011

Kowa identifies new cholesterol ester transfer protein inhibitors

Dec. 7, 2011

Amicus initiates phase II study of investigational chaperone with ERT in Pompe's disease

Dec. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
Other news to note for May 1, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: AC Immune, Aptose, Astrazeneca, Bioreference Health, Cardioline,...